A drug originally designed to help manage diabetes may also improve quality of life for patients with heart failure, according to a recent clinical trial.
Monthly Archives: October, 2019
High levels of folate, a B vitamin, can force glial nerve cells to transform back into undifferentiated stem cells, according to a new study published in the journal Stem Cells.
Funding has been announced for the first phase of an eight-year initiative to enable African hospitals to improve newborn survival by 50 percent, led by a consortium including Northwestern University.
Northwestern Medicine scientists have developed a new strategy to treat Parkinson’s disease by mitigating the effects of harmful genetic mutations, according to a recent study.
The second annual Women in Medicine symposium brought together Northwestern educators, scientists, trainees and students to highlight pioneering women and challenges still faced today.
Second-year medical students shared results from their ongoing Area of Scholarly Concentration (AOSC) research projects at a recent poster session.
Northwestern University Feinberg School of Medicine received a record $534 million in research funding and awards during the 2018-2019 fiscal year.
This article was originally published in the Breakthroughs Newsletter. Find more stories like this, as…
The use of long-acting bronchodilators to treat asthma had no impact for some African-American children, according to a new study from Ann & Robert H. Lurie Children’s Hospital of Chicago and the Department of Pediatrics.
A new Northwestern Medicine study found an experimental drug did not lower hospitalization among patients suffering from heart failure with preserved ejection fraction.